Literature DB >> 194730

Evaluation of the dual-precipitation method by comparison with the ultracentrifugation method for measurement of lipoproteins in serum.

P N Demacker, H E Vos-Janssen, A P Jansen, A van 't Laar.   

Abstract

We evaluated the dual-precipitation method for quantitative measurement of lipoproteins as described by Wilson and Spiger [J. Lab. Clin. Med. 82, 473 (1973)] for normo- and hyperlipemic sera, by comparison with the results obtained with ultracentrifugation. If serum with an above-normal triglyceride concentration is analyzed, the very-low-density lipoprotein cholesterol value obtained with the precipitation method is usually too low. For measurement of high-density lipoprotein cholesterol the ultracentrifugation and precipitation procedures give comparable results, but the latter method is preferred because sinking pre-beta-lipoproteins present in the high-density lipoprotein fraction isolated by means of the ultracentrifuge may result in falsely high values for cholesterol in that fraction. Therefore, at least for the determination of very-low-density lipoprotein cholesterol in hyperlipemic serum, the use of an ultracentrifuge remains necessary. Because few laboratories have an ultracentrifuge at their disposal, it seemed important to look at the stability of sera in view of the forwarding of samples. Also, a way of increasing the efficiency of the ultracentrifuge was studied. Sera can be stored for a week at 4 degrees C or for 54 h at room temperature without noticeable effect on lipoprotein values. Moreover, reliable values can be obtained with an ultracentrifugation time of 8 h (0.8 X 10(8) g-min).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194730

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells.

Authors:  M G Netea; N de Bont; P N Demacker; B J Kullberg; L E Jacobs; T J Verver-Jansen; A F Stalenhoef; J W Van der Meer
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Lipids and lipoproteins in Friedreich's ataxia.

Authors:  J L Walker; S Chamberlain; N Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

3.  Alterations in the metabolism of very-low- and low-density lipoproteins after partial ileal-bypass surgery in the Watanabe heritable hyperlipidaemic rabbit.

Authors:  M J Mol; A F Stalenhoef; P N Demacker; A van 't Laar
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

4.  Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.

Authors:  A F Stalenhoef; P N Demacker; J A Lutterman; A van't Laar
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

5.  Circulating lipoproteins are a crucial component of host defense against invasive Salmonella typhimurium infection.

Authors:  Mihai G Netea; Leo A B Joosten; Monique Keuter; Frank Wagener; Anton F H Stalenhoef; Jos W M van der Meer; Bart Jan Kullberg
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.